March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap on out-of-pocket costs for its weight-loss drugs, after the Medicare ...
Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.
14hon MSN
Shots like Ozempic are curbing ‘drug noise’ for addicts — so when will they be covered by insurance?
GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...
GlobalData on MSN
FDA approves GSK’s Wellcovorin for cerebral folate deficiency
FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.
Satisfaction with Medicare Advantage plans dropped last year, with overall satisfaction among members declining amid a drop ...
TGIF, and welcome to Health Brief. As is customary on Fridays, I’m wondering what’s on your mind. This Feedback Friday, shoot me a note, and let me know about a topic you’d like to hear more about.
5don MSN
Feeling frustrated with your Medicare Advantage plan? You’re not alone — member trust is falling
Medicare Advantage plans scored lower in overall satisfaction among members in 2025. Eroding trust and policy confusion drove the drop in customer satisfaction.
Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...
Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results